NEW YORK ─ Oct. 6, 2010 — Pfizer Animal Genetics is now accepting samples for Contractual Arachnodactyly (CA) testing. CA is a genetic condition formerly referred to as Fawn Calf Syndrome. Through the collaboration with Dr. Jon Beever at the University of Illinois and the American Angus Association (AAA), the gene mutation responsible for CA has been identified and a commercial test developed and validated. Pfizer Animal Genetics is approved by the American Angus Association as a CA testing laboratory.
CA is a nonlethal genetic condition that affects Angus and Angus-influenced cattle. While CA-affected calves are born alive, and most can walk, suckle and survive, their upper limb joints (particularly hip, stifle and hock) have a reduced range of motion. Calves appear normal by 4 to 6 months of age, but most perform poorly and are relatively tall and slender, with compromised feet and leg conformation. Click here for more information on the prevalence and importance of testing for CA.
Producers are encouraged to visit www.pfizeranimalgenetics.com for order forms and a sample collection guide, and to view ongoing updates and answers to frequently asked questions about CA testing. Additional questions may be answered by customer service at 877-BEEF DNA (877-233-3362).
About Pfizer Animal Genetics
Pfizer Animal Genetics is a business unit of Pfizer Animal Health, a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Inc. is the world’s largest research-based pharmaceutical company.
About Pfizer Animal Health
Pfizer Animal Health, a business of Pfizer Inc., is a world leader in discovering and developing innovative animal vaccines and prescription medicines, investing an estimated $300 million annually in animal health product research and development. For more information about how Pfizer Animal Health works to ensure a safe, sustainable global food supply from healthy livestock and poultry; or helps companion animals and horses to live longer, healthier lives, visit www.PfizerAH.com.